From: The role of environmental stress and DNA methylation in the longitudinal course of bipolar disorder
 | Baseline (n = 96) | 1-year follow-up (n = 95) | p-value |
---|---|---|---|
Sex | Â | Â | Â |
 Female | 50 | 50 |  |
Age, mean ± SD | 45.2 ± 12.4 | 46.17 ± 12.4 |  |
Duration of illness, mean ± SD | 13.52 ± 11.8 | 14.66 ± 11.8 |  |
DSM-IV diagnosis | Â | Â | Â |
 BD-I | 79 | 78 |  |
 BD-II | 17 | 17 |  |
Medication | Â | Â | Â |
 Combo therapy | 81 | 75 |  |
 Monotherapy | 14 | 16 |  |
 No meds | 1 | 4 |  |
Childhood trauma (yes) | 48 | 48 | Â |
LEQ scores, mean ± SD |  |  |  |
 Bad events | 10.2 ± 13.8 | 6.3 ± 6.6 | 0.004b |
 Good events | 9.7 ± 10.2 | 8.4 ± 7.6 | 0.191b |
 Total events | 19.9 ± 18.4 | 14.1 ± 10.7 | 0.001b |
Symptom ratings | Â | Â | Â |
 GAF, mean ± SD | 61.5 ± 12.6 | 65.8 ± 12.4 | 0.032a |
 YMRS sum, mean ± SD | 3.9 ± 5.8 | 2.4 ± 3.7 | 0.216b |
 IDS-C30, mean ± SD | 13.7 ± 11.0 | 10.6 ± 9.7 | 0.124b |
 PANSS sum, mean ± SD | 42.8 ± 11.8 | 39.2 ± 9.6 | 0.063b |